IL31RA and neoplasm: Therefore, targeting E2s to inhibit neddylation modification blocks the protein neddylation pathway and deactivates CRLs, triggering the aggregation of tumor-suppressive CRL substrates, stopping the cell cycle and impeding tumor growth and metastasis.